Suresh Babu, V.; Bisht, A.; Mallipatna, A.; SA, D.; Dudeja, G.; Kannan, R.; Shetty, R.; Guha, N.; Heymans, S.; Ghosh, A.
Enhanced Epithelial-to-Mesenchymal Transition and Chemoresistance in Advanced Retinoblastoma Tumors Is Driven by miR-181a. Cancers 2022, 14, 5124.
https://doi.org/10.3390/cancers14205124
AMA Style
Suresh Babu V, Bisht A, Mallipatna A, SA D, Dudeja G, Kannan R, Shetty R, Guha N, Heymans S, Ghosh A.
Enhanced Epithelial-to-Mesenchymal Transition and Chemoresistance in Advanced Retinoblastoma Tumors Is Driven by miR-181a. Cancers. 2022; 14(20):5124.
https://doi.org/10.3390/cancers14205124
Chicago/Turabian Style
Suresh Babu, Vishnu, Anadi Bisht, Ashwin Mallipatna, Deepak SA, Gagan Dudeja, Ramaraj Kannan, Rohit Shetty, Nilanjan Guha, Stephane Heymans, and Arkasubhra Ghosh.
2022. "Enhanced Epithelial-to-Mesenchymal Transition and Chemoresistance in Advanced Retinoblastoma Tumors Is Driven by miR-181a" Cancers 14, no. 20: 5124.
https://doi.org/10.3390/cancers14205124
APA Style
Suresh Babu, V., Bisht, A., Mallipatna, A., SA, D., Dudeja, G., Kannan, R., Shetty, R., Guha, N., Heymans, S., & Ghosh, A.
(2022). Enhanced Epithelial-to-Mesenchymal Transition and Chemoresistance in Advanced Retinoblastoma Tumors Is Driven by miR-181a. Cancers, 14(20), 5124.
https://doi.org/10.3390/cancers14205124